173 related articles for article (PubMed ID: 14587962)
21. Intravenous proton pump inhibitors before endoscopy in bleeding peptic ulcer with high-risk stigmata: a multicentre comparative study.
Andrews CN; Levy A; Fishman M; Hahn M; Atkinson K; Kwan P; Enns R
Can J Gastroenterol; 2005 Nov; 19(11):667-71. PubMed ID: 16292361
[TBL] [Abstract][Full Text] [Related]
22. The efficacy of proton-pump inhibitors in acute ulcer bleeding: a qualitative review.
Bustamante M; Stollman N
J Clin Gastroenterol; 2000 Jan; 30(1):7-13. PubMed ID: 10636205
[TBL] [Abstract][Full Text] [Related]
23. Omeprazole. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in peptic ulcer disease and Zollinger-Ellison syndrome.
Clissold SP; Campoli-Richards DM
Drugs; 1986 Jul; 32(1):15-47. PubMed ID: 3527658
[TBL] [Abstract][Full Text] [Related]
24. [Proton pump blockers and their significance in gastroenterology].
Dítĕ P; Prásek J
Vnitr Lek; 1995 Aug; 41(8):549-54. PubMed ID: 7483340
[TBL] [Abstract][Full Text] [Related]
25. Antisecretory therapy for bleeding peptic ulcer.
Peterson WL; Cook DJ
JAMA; 1998 Sep; 280(10):877-8. PubMed ID: 9739959
[No Abstract] [Full Text] [Related]
26. Switching between intravenous and oral pantoprazole.
Pisegna JR
J Clin Gastroenterol; 2001 Jan; 32(1):27-32. PubMed ID: 11154164
[TBL] [Abstract][Full Text] [Related]
27. Acid suppression in critically ill patients: what does the evidence support?
Spirt MJ
Pharmacotherapy; 2003 Oct; 23(10 Pt 2):87S-93S. PubMed ID: 14587963
[TBL] [Abstract][Full Text] [Related]
28. Maintenance oral pantoprazole therapy is effective for patients with Zollinger-Ellison syndrome and idiopathic hypersecretion.
Metz DC; Soffer E; Forsmark CE; Cryer B; Chey W; Bochenek W; Pisegna JR
Am J Gastroenterol; 2003 Feb; 98(2):301-7. PubMed ID: 12591045
[TBL] [Abstract][Full Text] [Related]
29. Pantoprazole IV (Protonix IV).
Med Lett Drugs Ther; 2002 Apr; 44(1129):41-2. PubMed ID: 11981511
[No Abstract] [Full Text] [Related]
30. [Proton pump inhibitors in pediatrics].
Faure C; Pelatan C; Languepin J
Arch Pediatr; 1999 Jun; 6(6):650-6. PubMed ID: 10394458
[TBL] [Abstract][Full Text] [Related]
31. Protonix. First i.v. proton pump inhibitor approved.
Nursing; 2002 Feb; 32(2):18, 20. PubMed ID: 11924161
[No Abstract] [Full Text] [Related]
32. Drug therapy of peptic ulcer disease.
Ching CK; Lam SK
Br J Hosp Med; 1995 Jul 12-Aug 15; 54(2-3):101-6. PubMed ID: 7551483
[TBL] [Abstract][Full Text] [Related]
33. Long-term treatment with lansoprazole for patients with Zollinger-Ellison syndrome.
Hirschowitz BI; Mohnen J; Shaw S
Aliment Pharmacol Ther; 1996 Aug; 10(4):507-22. PubMed ID: 8853754
[TBL] [Abstract][Full Text] [Related]
34. Pharmacology of acid suppression in the hospital setting: focus on proton pump inhibition.
Pisegna JR
Crit Care Med; 2002 Jun; 30(6 Suppl):S356-61. PubMed ID: 12072661
[TBL] [Abstract][Full Text] [Related]
35. Stress-related mucosal disease in the critically ill patient: risk factors and strategies to prevent stress-related bleeding in the intensive care unit.
Steinberg KP
Crit Care Med; 2002 Jun; 30(6 Suppl):S362-4. PubMed ID: 12072662
[TBL] [Abstract][Full Text] [Related]
36. [Antisecretor treatment of digestive hemorrhage associated to peptic ulcer: an approximation to the available evidence].
Bustamante Baléna M; Ponce García J
Rev Clin Esp; 2004 Mar; 204(3):161-8. PubMed ID: 15025985
[No Abstract] [Full Text] [Related]
37. Symptom relief in gastroesophageal reflux disease: a randomized, controlled comparison of pantoprazole and nizatidine in a mixed patient population with erosive esophagitis or endoscopy-negative reflux disease.
Armstrong D; Paré P; Pericak D; Pyzyk M;
Am J Gastroenterol; 2001 Oct; 96(10):2849-57. PubMed ID: 11695354
[TBL] [Abstract][Full Text] [Related]
38. Nonsteroidal anti-inflammatory drugs: add an anti-ulcer drug for patients at high risk only. Always limit the dose and duration of treatment with NSAIDs.
Prescrire Int; 2011 Sep; 20(119):216-9. PubMed ID: 21954519
[TBL] [Abstract][Full Text] [Related]
39. Use of proton-pump inhibitors in complicated ulcer disease and upper gastrointestinal tract bleeding.
Howden CW
Am J Health Syst Pharm; 1999 Dec; 56(23 Suppl 4):S5-11. PubMed ID: 10597118
[TBL] [Abstract][Full Text] [Related]
40. Effects of pantoprazole, a novel H+/K+-ATPase inhibitor, on duodenal ulcerogenic and healing responses in rats: a comparative study with omeprazole and lansoprazole.
Takeuchi K; Konaka A; Nishijima M; Kato S; Yasuhiro T
J Gastroenterol Hepatol; 1999 Mar; 14(3):251-7. PubMed ID: 10197495
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
